Heart Rhythm
Volume 6, Issue 9 , Pages 1276-1279, September 2009

Anticoagulation of patients on chronic warfarin undergoing arrhythmia device surgery: Wide variability of perioperative bridging in Canada

  • Andrew D. Krahn, MD

      Affiliations

    • University of Western Ontario, London, Ontario, Canada, Hamilton Health Sciences Center, Hamilton, Ontario, Canada
    • Corresponding Author InformationAddress reprint requests and correspondence: Dr. Andrew D. Krahn, C6-113, London Health Sciences Centre University Campus, 339 Windermere Road, London, Ontario, Canada N6A 5A5
  • ,
  • Jeffrey S. Healey, MD

      Affiliations

    • University of Western Ontario, London, Ontario, Canada, Hamilton Health Sciences Center, Hamilton, Ontario, Canada
  • ,
  • Christopher S. Simpson, MD

      Affiliations

    • Queen's University, Kingston, Ontario, Canada
  • ,
  • Vidal Essebag, MD

      Affiliations

    • McGill University Health Center and Sacré Coeur Hospital, Montreal, Quebec, Canada
  • ,
  • Soori Sivakumaran, MD

      Affiliations

    • University of Alberta Hospital, Edmonton, Alberta, Canada
  • ,
  • David H. Birnie, MD

      Affiliations

    • University of Ottawa Heart Institute, Ottawa, Ontario, Canada

Received 7 April 2009; accepted 27 May 2009. published online 08 June 2009.

Background

In patients undergoing cardiac rhythm device surgery, it is common practice to discontinue oral anticoagulation and to perform heparin bridging in order to reduce the risk of bleeding and minimize the risk of thromboembolic events.

Objective

The purpose of this study was to determine the perioperative anticoagulation strategies currently in use.

Methods

A survey presented four clinical scenarios of patients on oral anticoagulation undergoing cardiac rhythm device surgery. The scenarios represented a gradient of perceived thromboembolic risk based on the presence of atrial fibrillation, a mechanical heart valve, previous stroke, and the remainder of the CHADS2 risk factors (congestive heart failure, hypertension, age >75 years, diabetes, previous stroke or transient ischemic attack). Respondents were offered six options that included discontinuing oral anticoagulation without heparin, three different heparin bridging protocols, and ongoing oral anticoagulation with reduced or therapeutic dose warfarin.

Results

Based on responses from 38 (61%) of 62 electrophysiologists surveyed across Canada, 83% of respondents held warfarin without bridging in a low-risk, 78-year-old patient with atrial fibrillation (CHADS2 score 1). In three higher-risk patient scenarios, 67% to 100% of respondents chose heparin bridging or ongoing warfarin; 38% to 72% of respondents chose heparin bridging, with 23% to 36% choosing variable use of ongoing warfarin. In all three cases where respondents indicated that they would bridge, each of the three heparin regimens was chosen by at least 20% of respondents.

Conclusion

There is a wide range of approaches to perioperative management in patients on oral anticoagulation undergoing cardiac rhythm device surgery. Clinical equipoise is evident and supports the need for comparative studies.

Keywords: Anticoagulation, Pacemaker, Bridging, Heparin

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Dr. Krahn is a Career Investigator of the Heart and Stroke Foundation of Ontario and is supported by a grant from the Heart and Stroke Foundation of Ontario (NA3397). Dr. Essebag is the recipient of a Clinician Scientist Award from the Canadian Institutes of Health Research.

PII: S1547-5271(09)00576-1

doi:10.1016/j.hrthm.2009.05.027

Heart Rhythm
Volume 6, Issue 9 , Pages 1276-1279, September 2009